We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $34.32, moving +1.57% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.11%. Elsewhere, the Dow saw a downswing of 0.09%, while the tech-heavy Nasdaq depreciated by 1.88%.
Shares of the company have appreciated by 4.16% over the course of the past month, outperforming the Finance sector's loss of 3.61%, and the S&P 500's gain of 2.06%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on November 5, 2026. The company's earnings per share (EPS) are projected to be -$0.11, reflecting a 79.25% increase from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $4.72 billion, reflecting a 58.14% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $1.83 per share and a revenue of $18.81 billion, representing changes of +208.28% and +60.77%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 18.79% higher. Oscar Health, Inc. is currently a Zacks Rank #1 (Strong Buy).
In the context of valuation, Oscar Health, Inc. is at present trading with a Forward P/E ratio of 18.43. For comparison, its industry has an average Forward P/E of 10.09, which means Oscar Health, Inc. is trading at a premium to the group.
It's also important to note that OSCR currently trades at a PEG ratio of 0.37. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Insurance - Multi line industry stood at 0.95 at the close of the market yesterday.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 156, positioning it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts
Oscar Health, Inc. (OSCR - Free Report) closed the most recent trading day at $34.32, moving +1.57% from the previous trading session. The stock outpaced the S&P 500's daily loss of 1.11%. Elsewhere, the Dow saw a downswing of 0.09%, while the tech-heavy Nasdaq depreciated by 1.88%.
Shares of the company have appreciated by 4.16% over the course of the past month, outperforming the Finance sector's loss of 3.61%, and the S&P 500's gain of 2.06%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on November 5, 2026. The company's earnings per share (EPS) are projected to be -$0.11, reflecting a 79.25% increase from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $4.72 billion, reflecting a 58.14% rise from the equivalent quarter last year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $1.83 per share and a revenue of $18.81 billion, representing changes of +208.28% and +60.77%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 18.79% higher. Oscar Health, Inc. is currently a Zacks Rank #1 (Strong Buy).
In the context of valuation, Oscar Health, Inc. is at present trading with a Forward P/E ratio of 18.43. For comparison, its industry has an average Forward P/E of 10.09, which means Oscar Health, Inc. is trading at a premium to the group.
It's also important to note that OSCR currently trades at a PEG ratio of 0.37. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The average PEG ratio for the Insurance - Multi line industry stood at 0.95 at the close of the market yesterday.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 156, positioning it in the bottom 37% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.